# US 2014/0273114 A1 · Bacteria and method for synthesizing fatty acids

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2014/0273114 A1
- Document ID: US20140273114A1
- Status: Published application
- Kind: A1
- Application number: 14/350,544
- Filed: 2012-10-16
- Published: 2014-09-18
- Earliest claimed: 2011-10-17
- Assignees: William Marsh Rice University
- Applicants: William Marsh Rice University
- Inventors: Ka-Yiu San; Mai Li
- Web page: https://patentgrep.com/patent/US20140273114A1

## CPC

- C12N 15/70: Vectors or expression systems specially adapted for E. coli
- C07K 14/24: from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C12N 9/16: acting on ester bonds (3.1)
- C12N 15/52: Genes encoding for enzymes or proenzymes
- C12P 7/6409: Fatty acids
- C12Y 301/02014: Oleoyl-[acyl-carrier-protein] hydrolase (3.1.2.14), i.e. ACP-thioesterase
- Y02E 50/10: Biofuels, e.g. bio-diesel
- Y02P 20/52: using catalysts, e.g. selective catalysts
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Y: ENZYMES
- Y02E: REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02P: CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS

## Abstract

The present invention discloses a process for increasing the production of free fatty acids at high yield (close to maximum theoretical yield), with various fatty acid compositions and various percentage of fatty acids accumulated intracellularly. This invention will enable the efficient production of other products derived from free fatty acids and/or products that can be branched out from the fatty acid synthesis pathways.

## Claims

### Claim 1

A genetically engineered bacteria for producing fatty acids, said bacteria comprising a genotype comprising:
b) an overexpressed acyl ACP thioesterase (TE+);
c) one or more of an overexpressed FabZ+, FadR+, or FabH+;
d) zero, one or more of a ΔfadR, ΔsucC, ΔfabR, ΔfadD, or ΔptsG;
with the proviso that said bacteria does not have a genotype of ΔfadD ΔsucC TE+.

### Claim 2 (depends on 1)

The genetically engineered bacteria of claim 1, wherein the genotype of said bacteria comprises i) ΔsucC FabZ+ TE+; ii) ΔsucC ΔfabR FabZ+ TE+; iii) FabZ− TE+; iv) ΔfabR FadR+ TE+; or v) ΔsucC ΔfabR FadR+ TE+.

### Claim 3 (depends on 1)

The genetically engineered bacteria of claim 1, wherein the genotype of said bacteria comprises ΔsucC FabZ+ TE+.

### Claim 4 (depends on 1)

The genetically engineered bacteria of claim 1, wherein the genotype of said bacteria comprises ΔfadD ΔsucC FabZ+ TE+.

### Claim 5 (depends on 1)

The genetically engineered bacteria of claim 1, wherein the genotype of said bacteria comprises a genotype selected from the group consisting of:
(1) ΔfadD ΔfabR acyl-ACP thioesterase−
(2) ΔfadD ΔfabR fabZ+ acyl-ACP thioesterase+
(3) ΔfadD ΔfadR acyl-ACP thioesterase−
(4) ΔfadD ΔfadR fabZ+ acyl-ACP thioesterase+
(5) ΔfadD ΔfadR ΔfabR acyl-ACP thioesterase+
(6) ΔfadD fabZ+ acyl-ACP thioesterase+
(7) ΔfadD fadR+ acyl-ACP thioesterase+
(8) ΔfadD ΔsucC ΔfabR acyl-ACP thioesterase+
(9) ΔfadD ΔsucC ΔfabR fabZ+ acyl-ACP thioesterase+
(10) ΔfadD ΔsucC ΔfadR acyl-ACP thioesterase+
(11) ΔfadD ΔsucC ΔfadR fabZ+ acyl-ACP thioesterase+
(12) ΔfadD ΔsucC ΔfabR ΔfadR acyl-ACP thioesterase+
(13) ΔfadD ΔsucC fabZ+ acyl-ACP thioesterase+
(14) ΔfadD ΔsucC fadR+ acyl-ACP thioesterase+
(15) ΔfabR acyl-ACP thioesterase+
(16) ΔfabR fabZ+ acyl-ACP thioesterase+
(17) ΔfadR acyl-ACP thioesterase+
(18) ΔfadR fabZ+ acyl-ACP thioesterase+
(19) ΔfadR ΔfabR acyl-ACP thioesterase+
(20) fabZ+ acyl-ACP thioesterase+
(21) fadR+ acyl-ACP thioesterase+
(22) ΔsucC ΔfabR acyl-ACP thioesterase+
(23) ΔsucC ΔfabR fabZ+ acyl-ACP thioesterase+
(24) ΔsucC ΔfadR acyl-ACP thioesterase+
(25) ΔsucC ΔfadR fabZ+ acyl-ACP thioesterase+
(26) ΔfadD ΔsucC ΔfabR ΔfadR acyl-ACP thioesterase+
(27) ΔfadD ΔsucC fabZ+ acyl-ACP thioesterase+
(28) ΔfadD ΔsucC fadR+ acyl-ACP thioesterase+
(29) ΔfadD ΔfabR fadR+ acyl-ACP thioesterase+
(30) ΔfabR fadR+ acyl-ACP thioesterase−
(31) ΔfadD ΔsucC ΔfabR fadR+ acyl-ACP thioesterase+
(32) ΔsucC ΔfabR fadR+ acyl-ACP thioesterase+
(33) ΔfadD ΔptsG fabH+ acyl-ACP thioesterase+
(34) ΔptsG fabH+ acyl-ACP thioesterase+.

### Claim 6 (depends on 1)

The genetically engineered bacteria of claim 1, wherein said bacteria produces at least 14% more fatty acid than having a control microorganism having ΔfadD plus TE+.

### Claim 7 (depends on 1)

The genetically engineered bacteria of claim 1, wherein said bacteria produces at least 45% more fatty acid than having a control microorganism having ΔfadD plus TE+.

### Claim 8 (depends on 1)

The genetically engineered bacteria of claim 1, wherein said bacteria produces at least 65% more fatty acid than having a control microorganism having ΔfadD plus TE+.

### Claim 9 (depends on 1)

The genetically engineered bacteria of claim 1, wherein said bacteria produces at least 80% more fatty acid than having a control microorganism having ΔfadD plus TE+.

### Claim 10

A genetically engineered bacteria for producing increased amounts of fatty acids, said bacteria comprising a genotype selected from the group consisting of:
(1) ΔsucC fabZ+ acyl-ACP thioesterase+
(2) ΔsucC ΔfabR fabZ+ acyl-ACP thioesterase+
(3) fabZ+ acyl-ACP thioesterase+
(4) fadR+ acyl-ACP thioesterase+
(5) ΔsucC ΔfabR acyl-ACP thioesterase+
(6) ΔfabR acyl-ACP thioesterase−
(7) ΔfadR fabZ+ acyl-ACP thioesterase+
(8) ΔfabR fabZ+ acyl-ACP thioesterase+
(9) ΔfadD ΔsucC fabZ+ acyl-ACP thioesterase+
(10) ΔfadD ΔsucC ΔfabR fabZ+ acyl-ACP thioesterase+
(11) ΔfadD fabZ+ acyl-ACP thioesterase+
(12) ΔfadD fadR+ acyl-ACP thioesterase+
(13) ΔfadD ΔsucC ΔfabR acyl-ACP thioesterase+
(14) ΔfadD ΔfabR acyl-ACP thioesterase+
(15) ΔfadD ΔfadR fabZ+ acyl-ACP thioesterase+
(16) ΔfadD ΔfabR fabZ+ acyl-ACP thioesterase+
(17) ΔfadD ΔfabR fadR+ acyl-ACP thioesterase+
(18) ΔfabR fadR+ acyl-ACP thioesterase−
(19) ΔfadD ΔsucC ΔfabR fadR− acyl-ACP thioesterase+
(20) ΔsucC ΔfabR fadR+ acyl-ACP thioesterase+
(21) ΔfadD ΔptsG fabH+ acyl-ACP thioesterase+.

### Claim 11

A genetically engineered Enterobacteriaceae comprising ΔfadD ΔsucC FabZ+ TE+.

### Claim 12

A genetically engineered Enterobacteriaceae comprising ΔfadD ΔsucC ΔfabR FabZ+ TE+.

### Claim 13

A genetically engineered Enterobacteriaceae comprising ΔfadD FabZ+ TE+.

### Claim 14

A genetically engineered Enterobacteriaceae comprising ΔsucC FabZ+ TE+.

### Claim 15

A genetically engineered Enterobacteriaceae comprising ΔsucC ΔfabR FabZ+ TE+.

### Claim 16

A genetically engineered Enterobacteriaceae comprising FabZ+ TE+.

### Claim 17 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16)

A method of producing fatty acids, comprising culturing a genetically engineered bacteria of any of claim 1-16 in a culture medium under conditions effective for the production of fatty acids; and harvesting said fatty acids from said bacteria and/or the culture medium.

### Claim 18 (depends on 17)

The method of producing fatty acids of claim 17, comprising adding acetic acid to said culture medium and harvesting the fatty acids from said culture medium.

### Claim 19

A method of producing fatty acids, comprising culturing a genetically engineered bacteria in a culture medium under conditions effective for the production of fatty acids; and harvesting said fatty acids from the microorganism and/or the culture medium, wherein the bacteria and the fatty acid profile are selected from the group consisting of those listed in Table 2.

### Claim 20 (depends on 19)

The method of claim 19, wherein the bacteria and the fatty acid profile are selected from the group consisting of:
Bacteria:
Fatty Acid Profile:
ΔfadD ΔfabR TE+
about 60% C16:1
ΔfadD ΔfadR TE+
about 60% C14
ΔfadD ΔfadR FabZ+ TE+
about 60% C14
ΔfadD FabA+ TE+
about 90% C16
